Ferté C - Search Results

1

[Clinical equipoise and randomised clinical trials in oncology].

Ferté C, Hollebecque A, Salleron J, Penel N. Ferté C, et al. Bull Cancer. 2009 Jun;96(6):727-31. doi: 10.1684/bdc.2009.0880. Bull Cancer. 2009. PMID: 19470421 French.

2

[Prognostic and predictive factors of soft tissue sarcoma: a daily use of translational research].

Ferté C, Pascal LB, Penel N. Ferté C, et al. Bull Cancer. 2009 Apr;96(4):451-60. doi: 10.1684/bdc.2009.0783. Bull Cancer. 2009. PMID: 19357019 Review. French.

3

[Merkel cell carcinoma: current diagnosis and treatment].

Mortier L, Mirabel X, Ferte C, Penel N. Mortier L, et al. Among authors: ferte c. Bull Cancer. 2008 Sep;95(9):823-7. doi: 10.1684/bdc.2008.0673. Bull Cancer. 2008. PMID: 18829415 Review. French.

4

"Classical 3 + 3 design" versus "accelerated titration designs": analysis of 270 phase 1 trials investigating anti-cancer agents.

Penel N, Isambert N, Leblond P, Ferte C, Duhamel A, Bonneterre J. Penel N, et al. Among authors: ferte c. Invest New Drugs. 2009 Dec;27(6):552-6. doi: 10.1007/s10637-008-9213-5. Epub 2009 Jan 10. Invest New Drugs. 2009. PMID: 19132294

5

Phase II trials in patients with carcinoma of unknown primary: a pooled data analysis.

Adenis A, Ferté C, Penel N. Adenis A, et al. Among authors: ferte c. Invest New Drugs. 2010 Apr;28(2):178-84. doi: 10.1007/s10637-009-9261-5. Epub 2009 May 8. Invest New Drugs. 2010. PMID: 19424663

6

Dose-levels and first signs of efficacy in contemporary oncology phase 1 clinical trials.

Ferte C, Soria JC, Penel N. Ferte C, et al. PLoS One. 2011 Mar 2;6(3):e16633. doi: 10.1371/journal.pone.0016633. PLoS One. 2011. PMID: 21415927 Free PMC article.

7

Predictive value of clinical judgment of tumour progression in phase II trials.

Kotecki N, Penel N, Adenis A, Ferte C, Clisant S. Kotecki N, et al. Among authors: ferte c. PLoS One. 2012;7(12):e52638. doi: 10.1371/journal.pone.0052638. Epub 2012 Dec 26. PLoS One. 2012. PMID: 23300731 Free PMC article.

8

Development and validation of a bedside score to predict early death in cancer of unknown primary patients.

Penel N, Negrier S, Ray-Coquard I, Ferte C, Devos P, Hollebecque A, Sawyer MB, Adenis A, Seve P. Penel N, et al. Among authors: ferte c. PLoS One. 2009 Aug 3;4(8):e6483. doi: 10.1371/journal.pone.0006483. PLoS One. 2009. PMID: 19649260 Free PMC article.

9

Life-expectancy of patients enrolled in phase 1 clinical trials: a systematic review of published prognostic models.

Ploquin A, Olmos D, Ferté C, Cassier PA, Kramar A, Duhamel A, Penel N. Ploquin A, et al. Among authors: ferte c. Crit Rev Oncol Hematol. 2012 Aug;83(2):242-8. doi: 10.1016/j.critrevonc.2011.11.008. Epub 2012 Jan 9. Crit Rev Oncol Hematol. 2012. PMID: 22226569 Review.

10

Individual life expectancy estimation using validated prognostic scores for patients with cancer of unknown primary.

Ferté C, Penel N, Bonneterre J, Adenis A. Ferté C, et al. Oncology. 2010;78(2):87-93. doi: 10.1159/000306137. Epub 2010 Mar 30. Oncology. 2010. PMID: 20357516 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters